dihexa clinical trials human studies Unlocking the Potential of Peptide for Enhanced Cognitive Function Human Factors Testing and Clinical
Description
This investigational drug targets both GLP-1 and GIP receptors, resulting in up to 20% weight loss over 52 weeks
Translational Gap: Moderate to High
Please call Vaers at 800-822-7967 or vaers.hss.gov or so at least they know this is another side effect Im experiencing this after my 2nd Moderna shot
No significant adverse events have been documented in animal studies even at doses far exceeding typical human protocols
No, there will be no charges at the lab
